SVB Wealth LLC Has $1.47 Million Stake in UiPath Inc. (NYSE:PATH)

SVB Wealth LLC grew its holdings in shares of UiPath Inc. (NYSE:PATH) by 95.4% in the 4th quarter, Holdings Channel reports. The fund owned 59,216 shares of the healthcare company’s stock after buying an additional 28,910 shares during the period. SVB Wealth LLC’s holdings in UiPath were worth $1,471,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Royal London Asset Management Ltd. raised its stake in UiPath by 5.9% during the third quarter. Royal London Asset Management Ltd. now owns 139,544 shares of the healthcare company’s stock worth $2,388,000 after acquiring an additional 7,742 shares in the last quarter. O Shaughnessy Asset Management LLC bought a new stake in shares of UiPath during the third quarter worth about $203,000. Invesco Ltd. grew its holdings in shares of UiPath by 2.8% during the third quarter. Invesco Ltd. now owns 399,181 shares of the healthcare company’s stock worth $6,830,000 after purchasing an additional 10,863 shares during the last quarter. Symmetry Partners LLC bought a new stake in shares of UiPath during the fourth quarter worth about $205,000. Finally, Toroso Investments LLC grew its holdings in shares of UiPath by 196.7% during the third quarter. Toroso Investments LLC now owns 78,189 shares of the healthcare company’s stock worth $1,338,000 after purchasing an additional 51,834 shares during the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Stock Performance

UiPath stock opened at $19.04 on Friday. UiPath Inc. has a 52-week low of $12.38 and a 52-week high of $27.87. The stock’s 50 day moving average price is $22.97 and its two-hundred day moving average price is $21.44.

UiPath (NYSE:PATH) last issued its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The company had revenue of $405.25 million for the quarter, compared to analyst estimates of $383.32 million. Analysts anticipate that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $21.66, for a total transaction of $866,400.00. Following the transaction, the chief financial officer now directly owns 660,762 shares of the company’s stock, valued at $14,312,104.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold 72,000 shares of company stock valued at $1,591,360 over the last ninety days. 31.03% of the stock is owned by company insiders.

Analyst Ratings Changes

PATH has been the topic of several research reports. William Blair initiated coverage on UiPath in a report on Tuesday, January 2nd. They set an “outperform” rating on the stock. DA Davidson boosted their price target on UiPath from $20.00 to $24.00 and gave the stock a “neutral” rating in a report on Thursday, March 14th. JPMorgan Chase & Co. upgraded UiPath from a “neutral” rating to an “overweight” rating and upped their target price for the company from $22.00 to $28.00 in a report on Thursday, March 14th. Morgan Stanley upped their target price on UiPath from $17.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, March 14th. Finally, Wells Fargo & Company upped their target price on UiPath from $24.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, March 14th. Nine analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, UiPath currently has a consensus rating of “Moderate Buy” and an average price target of $27.41.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.